secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2021-07-27T23:59:59+00:00
Accession:  0000310764-21-000108
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q2 net sales $4.3B (+55% YoY), raises FY2021 guidance
-------------------------------------------------------------

- Reported net sales $4.3B, +55.4% from 2020 and +17.6% from 2019; organic net sales +42.9% from 2020.
- Reported EPS $1.55; adjusted EPS $2.25 (up from $0.64 in Q2 2020).
- Adjusted operating income margin 25.9% vs reported 17.0%.
- Orthopaedics $1.6B (+82.3%), MedSurg $1.7B (+32.3%), Neuro/Spine $0.9B (+66.9%) from 2020.
- Raises FY2021 outlook: organic net sales growth 9-10% from 2019; adj. EPS $9.25-$9.40.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076421000108/0000310764-21-000108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076421000108/syk-20210727.htm
  HTML page:      https://secwatch.observer/filing/0000310764-21-000108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer